ISSN: 0393-6155

Journal Home

Journal Guideline

International Journal of Biological Markers Q2 Unclaimed

Wichtig Publishing Srl Italy

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

International Journal of Biological Markers is a journal indexed in SJR in Medicine (miscellaneous) and Pathology and Forensic Medicine with an H index of 47. It has an SJR impact factor of 0,528 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,528.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Pathology and Forensic Medicine (Q2) Cancer Research (Q3) Clinical Biochemistry (Q3) Oncology (Q3)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

International Journal of Biological Markers

0,528

SJR Impact factor

47

H Index

27

Total Docs (Last Year)

126

Total Docs (3 years)

1051

Total Refs

263

Total Cites (3 years)

126

Citable Docs (3 years)

2.14

Cites/Doc (2 years)

38.93

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Brain irradiation-induced lymphocytosis predicts response in cancer patients with brain metastases

Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis

Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: Relationship to platelet a-granule content and primary activation

Immunohistochemical expression of fatty acid synthase, Ki-67

Immunohistochemical expression of p53 and Ki67 in colorectal adenomas and prediction of malignancy and development of new polyps

hMSH2 and hMLH1 gene expression patterns differ between lung adenocarcinoma and squamous cell carcinoma: correlation with patient survival and response to adjuvant chemotherapy treatment

Remembering Judah Moses Folkma

Serum calcitonin-negative medullary thyroid carcinoma: role of CgA and CEA as complementary markers

Gastrointestinal stromal tumors (GISTs): from science to targeted therapy

Assessment of the biological variation of plasma tissue inhibitor of metalloproteinases-1

Is the urokinase-type plasminogen activator system a reliable prognostic factor in gastric cancer?

Pharmacology of epidermal growth factor inhibitors

SHOW MORE ARTICLES

Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors

Poor usage of HUGO standard gene nomenclature in cancer marker studies

Confidence interval estimation for DNA and mRNA concentration by real-time PCR: A new environment for an old theorem

SMAD2 and the relationship of colorectal cancer to

Are 90K/MAC-2BP serum levels correlated with poor prognosis in HCC patients? Preliminary results

Role of monocyte chemoattractant protein-1, tumor necrosis factor-alpha and interleukin-6 in the control of malignant pleural effusion and survival in patients with primary lung adenocarcinoma

Expression of Mina53 and its significance in gastric carcinoma

Detection of cytokeratin 19 mRNA and CYFRA 21-1 (cytokeratin 19 fragments) in blood of Tunisian women with breast cancer

The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma

Treatment of advanced head and neck cancer with cetuximab

Increased expression of CD24 in nonmelanoma skin cancer

Stat3 expression in oral squamous cell carcinoma: association with clinicopathological parameters and survival